Dr Xinyu Zhou graduated from Northwest University, Xi’an, China, with a BS in Biotechnology. In 2018, he earned his PhD at The Ohio State University under the mentorship of Dr Jianjie Ma. While studying for his PhD, he investigated the regulation of calcium signaling in cardiac muscle. Dr Zhou also specializes in imaging and molecular and biochemical tools for translational research in tissue repair and regeneration. Currently a postdoctoral researcher in Dr Ma’s lab, Xinyu is continuing his work to advance the understanding of calcium signaling regulation and explore the potential treatment of heart disease. Outside of the lab, Xinyu enjoys family time with his wife and two children. He likes reading, photography, sports, and traveling.

Dr Ki Ho Park earned his BS in electrical engineering and a PhD in system engineering from the University of Tokushima, Japan. While studying the effects of electromagnetic fields on cells in his PhD program, his interest shifted from engineering to life sciences. He studied ion channels during his first postdoctoral fellowship at the Rutgers University Robert Wood Johnson Medical School, gaining extensive knowledge and skills in molecular biology, biochemistry, and electrophysiology. After joining Dr Jianjie Ma’s laboratory, he currently explores the role of proteins that regulate calcium signaling under cardiac stress or inflammation by using in vitro and in vivo imaging techniques. In his spare time, he loves watching movies and spending time with his family and friends.

Dr Qingxun Hu earned his MS in Biochemistry and Molecular Biology in Dr Yi Yang’s lab at East China University of Science and Technology, where his work focused on the development of biosensors for intracellular NAD(H) signals, including SoNar, FiNad, and Frex. He earned his PhD in Dr Yi Zhun Zhu’s lab at Fudan University, where he developed a novel H2S and NO conjugated donor for cardiovascular protection. Currently, his research focuses on mitochondrial dynamics, redox regulation, and protein modification in metabolic heart disease. He is also interested in dissecting compartmentalized NAD⁺/NADH ratios in live cells. He enjoys soccer and hiking with his beloved daughter and wife.

Dr Zhao Li earned his BS in Bioengineering and an MS in Pathology and Pathophysiology from Xi’an Jiaotong University, China. In 2017, he completed his PhD, also from Xi’an Jiaotong University. He is currently a postdoctoral fellow at The Center for Translational Medicine, The First Affiliated Hospital, Sun Yat-sen University. His research interests include endothelial dysfunction diseases, endothelial homeostasis and vascular remodelling, and the communication between lipid metabolism and endothelial function. While studying the mechanism in early sepsis and the possible treatments for it, he and his coauthors found that endothelial permeability and vascular leakage participate in early sepsis while maintaining endothelial function.

Dr Mingzhu Yin is a Professor and Co-Director of Dermatology at the Xiangya Hospital, Central South University, China. He earned his MD in Oncology from the Harbin Medical University in 2008 and his PhD in Integrated Traditional Chinese and Western Medicine from the China Pharmaceutical University (CPU) with Yale University Combined Training in 2015. He joined the Harbin Medical University as a Clinical Doctor in 2011 and the National Institute on Aging (NIA/NIH) as a Postdoctoral Scholar in 2012. Dr Yin’s research interests include the application of immune cell and microvessels to regulate transcoelomic, lymphatic and vascular metastasis of cancer.

Dr Tobias Petzold is currently working as an Associate Professor in the Department of Cardiology at Ludwig-Maximilian University (LMU) in Munich. In addition to his MD from LMU, he earned an MS in Biomedical Science from the University of Virginia. During his doctoral thesis at the Max-Planck- Institute for Biochemistry in Martinsried (mentor, Dr Reinhard Fässler), he investigated the mechanisms of platelet integrin activation. He completed his clinical training and postdoctoral studies under the supervision of. Dr Steffen Massberg at LMU. His research focuses on the mechanisms of platelet activation during thrombosis and novel antithrombotic therapies. At the 2017 meeting of the German Cardiac Society, Tobias Petzold and Amin Polzin decided to conduct their recent multicentric translational study. Outside of work, he enjoys spending time with his family in the mountains.

Dr Amin Polzin is an Associate Professor in the Department of Cardiology, Pneumology and Vascular Medicine of the University Hospital Düsseldorf (mentor, Dr Malte Kelm). As a clinical physician, he combines deep passion for interventional cardiology and science. Under the profound supervision of Dr Kelm, he was trained in clinical, translational and basic science. He extended his skills during research fellowships in the Institute of Pharmacology and Clinical Pharmacology at the Heinrich Heine University Düsseldorf and Institute of Pathophysiology in Essen. After working separately on similar projects regarding Factor IIa inhibition, Amin Polzin and Tobias Petzold joined forces on the present project to identify the role of Factor Xa in platelet activation.

Dr Manabu Nagao is an assistant professor at Kobe University in Japan. He earned his MD from Mie University School of Medicine and completed his PhD at Kobe University. Dr Nagao then joined the laboratory of Tom Quertermous at Stanford University as a postdoctoral scholar and investigated the molecular mechanisms behind genetic risk factors for human cardiovascular disease, especially focusing on vascular smooth muscle cells. Now, his interests are in cardiac metabolism under pathological conditions, including cardiac ischemia and diabetes. To gain further insights, he now devotes his research to studies in this field. Outside of the lab, he enjoys watching Sumo on TV.